Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin

BACKGROUND: Lytic reactivation of EBV has been reported to play an important role in human diseases, including NPC carcinogenesis. Inhibition of EBV reactivation is considered to be of great benefit in the treatment of virus-associated diseases. For this purpose, we screened for inhibitory compounds...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chung-Chun, Fang, Chih-Yeu, Cheng, Yu-Jhen, Hsu, Hui-Yu, Chou, Sheng-Ping, Huang, Sheng-Yen, Tsai, Ching-Hwa, Chen, Jen-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217310/
https://www.ncbi.nlm.nih.gov/pubmed/28056971
http://dx.doi.org/10.1186/s12929-016-0313-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217310/
https://www.ncbi.nlm.nih.gov/pubmed/28056971
http://dx.doi.org/10.1186/s12929-016-0313-9

Ejemplares similares